U-Systems raises $16.5m in funding:
This article was originally published in Clinica
Executive Summary
Developer of automated breast ultrasound systems U-Systems (San Jose, California) has raised an additional $16.5m in a series D financing round, bringing total funding to $44.5m. The new round, led by Siemens Venture Capital, enables U-Systems to expand sales and marketing of its FDA-cleared and CE-marked SomoVu automated breast ultrasound system, and continue investing in product development. Existing investors Sycamore Venture Capital, MDS Capital, Radius Ventures, Kinetic Capital and United Investments contributed to the round, as did new shareholders President International Development Corporation, iD Innovation, China Investment & Development Company and TSC Bioventures.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.